Incyte
INCY
492 hedge funds and large institutions have $16.5B invested in Incyte in 2021 Q1 according to their latest regulatory filings, with 57 funds opening new positions, 174 increasing their positions, 186 reducing their positions, and 74 closing their positions.
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
7% more call options, than puts
Call options by funds: $69.4M | Put options by funds: $65.1M
0.4% less ownership
Funds ownership: 92.83% → 92.43% (-0.4%)
6% less repeat investments, than reductions
Existing positions increased: 174 | Existing positions reduced: 186
4% less funds holding
Funds holding: 511 → 492 (-19)
7% less capital invested
Capital invested by funds: $17.7B → $16.5B (-$1.25B)
23% less first-time investments, than exits
New positions opened: 57 | Existing positions closed: 74
Top Buyers
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$103M |
| 2 |
HM
HealthCor Management
New York
|
+$96M |
| 3 |
Dodge & Cox
San Francisco,
California
|
+$90.9M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$67.9M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$57.2M |
Top Sellers
INCY Hedge Fund Activity: Q1 2021 in Review
492 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Incyte (INCY) for Q1 2021, worth a combined $16.5B — down 7.1% from $17.7B a quarter earlier.
Sellers outnumbered buyers: 74 funds closed out of INCY and 57 opened new positions — a net loss of 17 holders — while 186 trimmed existing stakes and 174 added.
The largest buyer was ARK Investment Management, adding an estimated $103M. The largest seller was T. Rowe Price Associates, cutting an estimated $216M.
- 492 institutional investors held Incyte (INCY) as of Q1 2021, down from 511 in Q4 2020.
- Funds reported $16.5B of Incyte stock for Q1 2021, down 7.1% quarter-over-quarter.
- 57 funds opened new Incyte positions in Q1 2021 and 74 closed out, a net change of -17 holders.
- The largest Incyte buyer in Q1 2021 was ARK Investment Management, an estimated $103M added.
- The largest Incyte seller in Q1 2021 was T. Rowe Price Associates, an estimated $216M sold.
Based on aggregated 13F filings for Q1 2021.